GT Biopharma, Inc. (GTBP)
NCM · Common · CUSIP 36254L100
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for GTBP and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
36254L100
Market Cap
Micro Cap
Business: GT Biopharma, Inc. is a clinical stage biopharmaceutical company focused on the development and commercialization of immuno-oncology therapeutic products based on our proprietary TriKE™ NK cell engager platform.

Company Contact

CEO
Michael Breen
CFO
Alan L. Urban
Headquarters
8000 Marina Blvd, Suite 100, Brisbane, CA 94005
Phone
415-919-4040 · Toll-Free 800-304-9888
Investor Relations
Corey Davis, LifeSci Advisors · 212-915-2577 · cdavis@lifesciadvisors.com
SEC EDGAR Filings
View filings »